KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 116 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $804,000 | +100.0% | 41,916 | +0.3% | 0.01% | +66.7% |
| Q3 2019 | $402,000 | +60.8% | 41,791 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $250,000 | +2.5% | 41,791 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $244,000 | -37.8% | 41,791 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $392,000 | – | 41,791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlphaCentric Advisors LLC | 1,125,000 | $1,698,750 | 1.02% |
| Palo Alto Investors LP | 5,102,193 | $7,704,311 | 0.87% |
| Birchview Capital, LP | 469,832 | $709,446 | 0.58% |
| Eversept Partners, LP | 5,016,320 | $7,574,643 | 0.50% |
| Altium Capital Management LP | 740,000 | $1,117,400 | 0.44% |
| Avidity Partners Management LP | 8,298,570 | $12,530,841 | 0.40% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 558,466 | $843,284 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,299,151 | $1,962 | 0.16% |
| Ikarian Capital, LLC | 409,355 | $618,126 | 0.07% |
| DAFNA Capital Management LLC | 192,678 | $290,944 | 0.07% |